Cycle Pharmaceuticals
Dr. Shriya Pancholi is a seasoned professional with extensive experience in product development and formulation science within the pharmaceutical industry. Currently serving as a Senior Product Development Manager at Cycle Pharmaceuticals since March 2024, Dr. Pancholi has previously led formulation and development as a Group Leader at Almac Group and contributed to the respiratory portfolio at GSK as a Senior Formulation Scientist. Dr. Pancholi's career began with roles at MedImmune, Novartis, and as a PhD research student at the University of Birmingham, where a doctoral project focused on biopharmaceutical formulation development. Educational credentials include a Ph.D. in Chemical Engineering and a BSc (Hons) in Pharmaceutical Science, underscoring a strong foundation in relevant scientific disciplines.
This person is not in any teams
Cycle Pharmaceuticals
1 followers
Cycle Pharmaceuticals was founded in 2012 with the sole aim of delivering best-in-class drug treatments and services to the under-served rare disease patient community.